Cargando…

Tools for the Quality Control of Pharmaceutical Heparin

Heparin is a vital pharmaceutical anticoagulant drug and remains one of the few naturally sourced pharmaceutical agents used clinically. Heparin possesses a structural order with up to four levels of complexity. These levels are subject to change based on the animal or even tissue sources that they...

Descripción completa

Detalles Bibliográficos
Autores principales: Devlin, Anthony, Mycroft-West, Courtney, Procter, Patricia, Cooper, Lynsay, Guimond, Scott, Lima, Marcelo, Yates, Edwin, Skidmore, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843833/
https://www.ncbi.nlm.nih.gov/pubmed/31557911
http://dx.doi.org/10.3390/medicina55100636
_version_ 1783468308626931712
author Devlin, Anthony
Mycroft-West, Courtney
Procter, Patricia
Cooper, Lynsay
Guimond, Scott
Lima, Marcelo
Yates, Edwin
Skidmore, Mark
author_facet Devlin, Anthony
Mycroft-West, Courtney
Procter, Patricia
Cooper, Lynsay
Guimond, Scott
Lima, Marcelo
Yates, Edwin
Skidmore, Mark
author_sort Devlin, Anthony
collection PubMed
description Heparin is a vital pharmaceutical anticoagulant drug and remains one of the few naturally sourced pharmaceutical agents used clinically. Heparin possesses a structural order with up to four levels of complexity. These levels are subject to change based on the animal or even tissue sources that they are extracted from, while higher levels are believed to be entirely dynamic and a product of their surrounding environments, including bound proteins and associated cations. In 2008, heparin sources were subject to a major contamination with a deadly compound—an over-sulphated chondroitin sulphate polysaccharide—that resulted in excess of 100 deaths within North America alone. In consideration of this, an arsenal of methods to screen for heparin contamination have been applied, based primarily on the detection of over-sulphated chondroitin sulphate. The targeted nature of these screening methods, for this specific contaminant, may leave contamination by other entities poorly protected against, but novel approaches, including library-based chemometric analysis in concert with a variety of spectroscopic methods, could be of great importance in combating future, potential threats.
format Online
Article
Text
id pubmed-6843833
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68438332019-11-25 Tools for the Quality Control of Pharmaceutical Heparin Devlin, Anthony Mycroft-West, Courtney Procter, Patricia Cooper, Lynsay Guimond, Scott Lima, Marcelo Yates, Edwin Skidmore, Mark Medicina (Kaunas) Review Heparin is a vital pharmaceutical anticoagulant drug and remains one of the few naturally sourced pharmaceutical agents used clinically. Heparin possesses a structural order with up to four levels of complexity. These levels are subject to change based on the animal or even tissue sources that they are extracted from, while higher levels are believed to be entirely dynamic and a product of their surrounding environments, including bound proteins and associated cations. In 2008, heparin sources were subject to a major contamination with a deadly compound—an over-sulphated chondroitin sulphate polysaccharide—that resulted in excess of 100 deaths within North America alone. In consideration of this, an arsenal of methods to screen for heparin contamination have been applied, based primarily on the detection of over-sulphated chondroitin sulphate. The targeted nature of these screening methods, for this specific contaminant, may leave contamination by other entities poorly protected against, but novel approaches, including library-based chemometric analysis in concert with a variety of spectroscopic methods, could be of great importance in combating future, potential threats. MDPI 2019-09-25 /pmc/articles/PMC6843833/ /pubmed/31557911 http://dx.doi.org/10.3390/medicina55100636 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Devlin, Anthony
Mycroft-West, Courtney
Procter, Patricia
Cooper, Lynsay
Guimond, Scott
Lima, Marcelo
Yates, Edwin
Skidmore, Mark
Tools for the Quality Control of Pharmaceutical Heparin
title Tools for the Quality Control of Pharmaceutical Heparin
title_full Tools for the Quality Control of Pharmaceutical Heparin
title_fullStr Tools for the Quality Control of Pharmaceutical Heparin
title_full_unstemmed Tools for the Quality Control of Pharmaceutical Heparin
title_short Tools for the Quality Control of Pharmaceutical Heparin
title_sort tools for the quality control of pharmaceutical heparin
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843833/
https://www.ncbi.nlm.nih.gov/pubmed/31557911
http://dx.doi.org/10.3390/medicina55100636
work_keys_str_mv AT devlinanthony toolsforthequalitycontrolofpharmaceuticalheparin
AT mycroftwestcourtney toolsforthequalitycontrolofpharmaceuticalheparin
AT procterpatricia toolsforthequalitycontrolofpharmaceuticalheparin
AT cooperlynsay toolsforthequalitycontrolofpharmaceuticalheparin
AT guimondscott toolsforthequalitycontrolofpharmaceuticalheparin
AT limamarcelo toolsforthequalitycontrolofpharmaceuticalheparin
AT yatesedwin toolsforthequalitycontrolofpharmaceuticalheparin
AT skidmoremark toolsforthequalitycontrolofpharmaceuticalheparin